[Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma]

Hautarzt. 1988 Mar;39(3):170-3.
[Article in German]

Abstract

Immunochemotherapy combining dacarbazine with BCG is a possible therapeutic method for the adjuvant treatment of malignant melanomas. The routes of application of BCG, however, vary. As the case of a 61-year-old female shows, subcutaneous injection can lead to severe ulcerations, which respond to tuberculostatic therapy. Therefore scarifications seems to be preferable.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • BCG Vaccine / administration & dosage
  • BCG Vaccine / adverse effects*
  • Combined Modality Therapy
  • Dacarbazine / therapeutic use
  • Female
  • Humans
  • Injections, Subcutaneous
  • Melanoma / drug therapy
  • Melanoma / therapy*
  • Middle Aged
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / therapy*
  • Skin Ulcer / etiology*

Substances

  • BCG Vaccine
  • Dacarbazine